2.69
2.69 (0%)
As of Feb 14, 2025
Citius Pharmaceuticals, Inc. [CTXR]
Source:
Company Overview
Citius Pharmaceuticals, Inc. headquartered in Cranford, New Jersey, is a bio pharmaceutical company dedicated to the development and commercialization of first-in-class critical care products.
| Country | United States |
| Headquarters | cranford, new jersey |
| Phone Number | (908) 967-6676 |
| Industry | manufacturing |
| CEO | Leonard Mazur |
| Website | www.citiuspharma.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | |
| Operating Profit | $-10 |
| Net Income | $-10.3 |
| Net Cash | $-2.2 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -8.7% |
| Profit as % of Stockholder Equity | -14.9% |
Management Effectiveness
| Return on Equity | -14.9% |
| Return on Assets | -8.5% |
| Turnover Ratio | |
| EBITA | $-10 |
Balance Sheet and Cash Flow Measures
| Total Assets | $120.7 |
| Total Liabilities | $51.8 |
| Operating Cash Flow | $-4.7 |
| Investing Cash Flow | |
| Financing Cash Flow | $2.6 |
